Follow
Kieng Vang Dings
Title
Cited by
Cited by
Year
Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire
MA Burchill, J Yang, KB Vang, JJ Moon, HH Chu, CWJ Lio, AL Vegoe, ...
Immunity 28 (1), 112-121, 2008
5122008
IL-2,-7, and-15, but not thymic stromal lymphopoeitin, redundantly govern CD4+ Foxp3+ regulatory T cell development
KB Vang, J Yang, SA Mahmud, MA Burchill, AL Vegoe, MA Farrar
The Journal of Immunology 181 (5), 3285-3290, 2008
3322008
Interleukin-2 receptor signaling in regulatory T cell development and homeostasis
MA Burchill, J Yang, KB Vang, MA Farrar
Immunology letters 114 (1), 1-8, 2007
2722007
Cutting edge: CD28 and c-Rel–dependent pathways initiate regulatory T cell development
KB Vang, J Yang, AJ Pagán, LX Li, J Wang, JM Green, AA Beg, MA Farrar
The Journal of Immunology 184 (8), 4074-4077, 2010
1392010
Identification of cellular sources of IL-2 needed for regulatory T cell development and homeostasis
DL Owen, SA Mahmud, KB Vang, RM Kelly, BR Blazar, KA Smith, ...
The Journal of Immunology 200 (12), 3926-3933, 2018
942018
Enhancement of T-cell–Mediated Antitumor Response: Angiostatic Adjuvant to Immunotherapy against Cancer
RPM Dings, KB Vang, K Castermans, F Popescu, Y Zhang, ...
Clinical Cancer Research 17 (10), 3134-3145, 2011
812011
The role of STAT5 in the development, function, and transformation of B and T lymphocytes
LM Heltemes‐Harris, MJL Willette, KB Vang, MA Farrar
Annals of the New York Academy of Sciences 1217 (1), 18-31, 2011
662011
The role of surface chemistry in the cytotoxicity profile of graphene
W Majeed, S Bourdo, DM Petibone, V Saini, KB Vang, ZA Nima, ...
Journal of Applied Toxicology 37 (4), 462-470, 2017
572017
Triple-negative breast cancer targeting and killing by EpCAM-directed, plasmonically active nanodrug systems
SV Jenkins, ZA Nima, KB Vang, G Kannarpady, DA Nedosekin, ...
NPJ precision oncology 1 (1), 27, 2017
472017
Evidence for early stage anti-tumor immunity elicited by spatially fractionated radiotherapy-immunotherapy combinations
AJ Johnsrud, SV Jenkins, A Jamshidi-Parsian, CM Quick, EP Galhardo, ...
Radiation research 194 (6), 688-697, 2020
352020
Sample storage conditions induce post-collection biases in microbiome profiles
SV Jenkins, KB Vang, A Gies, RJ Griffin, SR Jun, I Nookaew, RPM Dings
BMC microbiology 18, 1-9, 2018
332018
Modifying dendritic cell activation with plasmonic nano vectors
KB Vang, I Safina, E Darrigues, D Nedosekin, ZA Nima, W Majeed, ...
Scientific Reports 7 (1), 5513, 2017
322017
Gastrointestinal tract dysbiosis enhances distal tumor progression through suppression of leukocyte trafficking
SV Jenkins, MS Robeson, RJ Griffin, CM Quick, ER Siegel, MJ Cannon, ...
Cancer research 79 (23), 5999-6009, 2019
292019
Raman spectroscopy using plasmonic and carbon-based nanoparticles for cancer detection, diagnosis, and treatment guidance. Part 1: diagnosis
E Darrigues, ZA Nima, W Majeed, KB Vang-Dings, V Dantuluri, AR Biris, ...
Drug Metabolism Reviews 49 (2), 212-252, 2017
182017
Targeting artificial tumor stromal targets for molecular imaging of tumor vascular hypoxia
NA Koonce, J Levy, ME Hardee, A Jamshidi-Parsian, KB Vang, S Sharma, ...
PLoS One 10 (8), e0135607, 2015
172015
Raman spectroscopy using plasmonic and carbon-based nanoparticles for cancer detection, diagnosis, and treatment guidance. Part 2: Treatment
E Darrigues, V Dantuluri, ZA Nima, KB Vang-Dings, RJ Griffin, AR Biris, ...
Drug Metabolism Reviews 49 (2), 253-283, 2017
162017
Design of gold nanoparticles in dendritic cell‐based vaccines
RPM Dings, M Cannon, KB Vang
Particle & Particle Systems Characterization 35 (9), 1800109, 2018
152018
Graphene-based 2D constructs for enhanced fibroblast support
I Safina, SE Bourdo, KM Algazali, G Kannarpady, F Watanabe, KB Vang, ...
PLoS One 15 (5), e0232670, 2020
142020
Quantification of cellular associated graphene and induced surface receptor responses
ZA Nima, KB Vang, D Nedosekin, G Kannarpady, V Saini, SE Bourdo, ...
Nanoscale 11 (3), 932-944, 2019
142019
Dysbiotic stress increases the sensitivity of the tumor vasculature to radiotherapy and c-Met inhibitors
SV Jenkins, M Alimohammadi, AS Terry, RJ Griffin, AJ Tackett, JW Leung, ...
Angiogenesis 24, 597-611, 2021
32021
The system can't perform the operation now. Try again later.
Articles 1–20